Glutamine synthetase in cancer cell metabolism and oncogenesis
谷氨酰胺合成酶在癌细胞代谢和肿瘤发生中的作用
基本信息
- 批准号:9981701
- 负责人:
- 金额:$ 45.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AminesAmmoniaAnabolismBiochemical ProcessBioenergeticsBiologicalBiological ProcessBreastCancer cell lineCell Cycle ProgressionCell DeathCell LineCell ProliferationCell SurvivalCellsCellular Metabolic ProcessCitric Acid CycleClinicalCultured CellsDataDevelopmentDimensionsDiseaseEnzymesEssential Amino AcidsEventGenerationsGenetic TranscriptionGlucoseGlutamate DehydrogenaseGlutamate-Ammonia LigaseGlutamatesGlutamic AcidGlutaminaseGlutamineGrowthHumanKnowledgeLaboratoriesLeadLiver diseasesLungMalignant NeoplasmsMalignant neoplasm of lungMammary glandMediatingMetabolicMetabolismMicroRNAsModelingMolecularMusMutationNon-Essential Amino AcidNonesterified Fatty AcidsNucleotide BiosynthesisOncogenesOncogenicOutcomePancreasPathologicPatientsPharmacologyPhysical condensationPlayProcessProductionProto-OncogenesPublicationsReactionRegulationReportingRoleSamplingSignal PathwaySignal TransductionTestingThymine DNA GlycosylaseTissuesTricarboxylic Acidsalpha ketoglutarateanti-cancerbasec-myc Genescancer cellcancer typecell growthcell typedemethylationdeprivationdesigngenetic approachin vivoinhibitor/antagonistmalignant breast neoplasmmetabolic abnormality assessmentmetabolomicsmouse modelneoplasticneoplastic cellnervous system disordernew therapeutic targetnovelpancreatic cancer modelprogramspromoterpublic health relevancestable isotopesuccesstargeted cancer therapytherapeutic targettumortumor growthtumor metabolismtumor xenografttumorigenesistumorigenicuptake
项目摘要
SUMMARY
Dysregulated metabolism has long been recognized as a key hallmark of neoplastic disease. One of the major
metabolic changes in tumor cells is increased glutamine (Gln) usage via glutaminolysis: Gln is deaminated by
glutaminase (GLS) to glutamate (glutamic acid, Glu), which is converted by glutamate dehydrogenase (GLUD)
to α-ketoglutarate (aKG) to enter the tricarboxylic acid (TCA) cycle for anaplerosis (replenishment of metabolic
intermediates for energy production or biosynthesis). It is well recognized that oncogenic c-Myc (hereafter
referred to as Myc) enhances Gln usage by directly transactivating the expression of Gln transporters SLC1A5
and SLC7A5/SLC3A2, and by increasing GLS1 expression via transcriptional suppression of the GLS1
repressor micro RNAs (miR)-23a/b. Pharmacologically targeting GLS1 is being actively pursued as an anti-
cancer approach, although thus far with little success. On the other hand, several recent studies, including
those from our laboratory, point to the importance of Gln synthesis, at least in certain cell/tissue types. Gln is
synthesized de novo by condensation of Glu and ammonia, catalyzed by the enzyme Gln synthetase (GS, also
known as glutamate ammonia ligase, GLUL). Using stable isotope-based metabolite tracing, we recently
reported that this synthesized Gln is not used via glutaminolysis to fuel the TCA cycle; rather it is used for
several TCA-independent anabolic processes including biosynthesis of nucleotides and transport of essential
amino acids. Importantly, elevated expression of GS promoted cell survival under Gln limitation; inhibition of
GS led to decreased cell proliferation and increased cell death upon Gln limitation, and slowed xenograft tumor
growth. Moreover, we recently reported that Myc can induce the expression of GS in a number of cancer cell
lines. We also found a positive correlation between Myc activation and GS expression several mouse models
and in human patient samples. These findings lead us to propose the following hypothesis: oncogenic Myc,
at least in certain cell/tissue types, upregulates GS expression to promote Gln production and its
anabolic usage (away from the TCA cycle), thereby facilitating oncogenesis. We propose two Specific
Aims to study this hypothesis: 1) Study the metabolic and cell biological consequences, and the regulation of
increased GS expression in the context of Myc activation; and 2) Determine the in vivo role of GS in Myc-
driven metabolic reprogramming and oncogenesis. If accomplished, this study will provide a novel dimension
to understanding the functions of dysregulated Myc in cancer cells and a potential new target for treatment of
Myc-driven tumors.
摘要
长期以来,代谢失调一直被认为是肿瘤疾病的一个关键标志。其中一个主要的
肿瘤细胞的代谢变化是通过谷氨酰胺分解增加谷氨酰胺(Gln)的使用:Gln是通过
谷氨酰胺酶(GLS)转化为谷氨酸(Glu),由谷氨酸脱氢酶(Glud)转化
使α-酮戊二酸(AKG)进入三羧酸循环以恢复(代谢的补充
用于能源生产或生物合成的中间体)。众所周知,致癌的c-Myc(以下简称c-Myc
称为Myc)通过直接反式激活Gln转运体SLC1A5的表达来提高Gln的使用
和SLC7A5/SLC3A2,并通过转录抑制GLS1增加GLS1的表达
抑制物microRNAs(MiR)-23a/b。以GLS1为靶点的药理学研究正在积极地作为一种抗
癌症方法,尽管到目前为止收效甚微。另一方面,最近的几项研究,包括
我们实验室的那些人指出了谷氨酰胺合成的重要性,至少在某些细胞/组织类型中是这样。Gln是
谷氨酰胺合成酶(GS,又称谷氨酰胺合成酶)催化谷氨酸和氨缩合生成从头合成
称为谷氨酸氨连接酶,GLUL)。使用基于稳定同位素的代谢物追踪,我们最近
报道称,这种合成的谷氨酰胺不是通过谷氨酰胺分解来为三氯乙酸循环提供燃料的,而是用于
几个不依赖TCA的合成代谢过程,包括核苷酸的生物合成和必需物质的运输
氨基酸。重要的是,GS的高表达促进了谷氨酰胺限制下的细胞存活;抑制
GS抑制Gln诱导细胞增殖,增加细胞死亡,延缓移植瘤生长
成长。此外,我们最近报道Myc可以诱导一些癌细胞中GS的表达
台词。我们还发现Myc的激活与GS的表达在几个小鼠模型中呈正相关
以及在人类患者样本中。这些发现导致我们提出以下假设:致癌Myc,
至少在某些细胞/组织类型中,上调GS的表达以促进Gln的产生和其
使用合成代谢(远离三氯乙酸循环),从而促进肿瘤的发生。我们提出了两个具体的
目的是研究这一假说:1)研究代谢和细胞生物学后果,以及对
在Myc激活的背景下增加GS的表达;以及2)确定GS在Myc-1中的体内作用。
驱动新陈代谢重新编程和肿瘤发生。如果完成,这项研究将提供一个新的维度
了解Myc基因在肿瘤细胞中的功能及治疗肿瘤的新靶点
由MYC驱动的肿瘤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wei-Xing Zong其他文献
Wei-Xing Zong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wei-Xing Zong', 18)}}的其他基金
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
膜运输和代谢中的 PI3 激酶 PIK3CB (p110beta)
- 批准号:
10001471 - 财政年份:2018
- 资助金额:
$ 45.14万 - 项目类别:
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
膜运输和代谢中的 PI3 激酶 PIK3CB (p110beta)
- 批准号:
10474502 - 财政年份:2018
- 资助金额:
$ 45.14万 - 项目类别:
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
膜运输和代谢中的 PI3 激酶 PIK3CB (p110beta)
- 批准号:
10249278 - 财政年份:2018
- 资助金额:
$ 45.14万 - 项目类别:
Glutamine synthetase in cancer cell metabolism and oncogenesis
谷氨酰胺合成酶在癌细胞代谢和肿瘤发生中的作用
- 批准号:
10473698 - 财政年份:2018
- 资助金额:
$ 45.14万 - 项目类别:
Protein and redox homeostasis in cancer development and therapy
癌症发展和治疗中的蛋白质和氧化还原稳态
- 批准号:
10413025 - 财政年份:2008
- 资助金额:
$ 45.14万 - 项目类别:
相似国自然基金
SIRT5/ammonia信号通路介导适应性自噬在急性心肌梗死中的作用及其机制研究
- 批准号:81900312
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Powering Small Craft with a Novel Ammonia Engine
用新型氨发动机为小型船只提供动力
- 批准号:
10099896 - 财政年份:2024
- 资助金额:
$ 45.14万 - 项目类别:
Collaborative R&D
STTR Phase I: Microwave-Enhanced Modular Ammonia Synthesis
STTR 第一阶段:微波增强模块化氨合成
- 批准号:
2335104 - 财政年份:2024
- 资助金额:
$ 45.14万 - 项目类别:
Standard Grant
ENTICE: Enhanced Ammonia Cracking to Improve Engine Combustion and Emissions
ENTICE:增强氨裂解以改善发动机燃烧和排放
- 批准号:
10096979 - 财政年份:2024
- 资助金额:
$ 45.14万 - 项目类别:
Collaborative R&D
Development of in situ ammonia capture for enhanced catalytic ammonia synthesis
开发用于增强催化氨合成的原位氨捕获
- 批准号:
24K17765 - 财政年份:2024
- 资助金额:
$ 45.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EAGER: Enhancement of Ammonia combustion by spatiotemporal control of plasma kinetics
EAGER:通过等离子体动力学的时空控制增强氨燃烧
- 批准号:
2337461 - 财政年份:2024
- 资助金额:
$ 45.14万 - 项目类别:
Standard Grant
Manufacturing conductive oxides as catalyst support for energy efficient production of hydrogen and ammonia
制造导电氧化物作为氢和氨节能生产的催化剂载体
- 批准号:
2904783 - 财政年份:2024
- 资助金额:
$ 45.14万 - 项目类别:
Studentship
Novel High-Efficiency Ammonia engine Technology for Heavy Duty marine applications (HEAT-HD)
适用于重型船舶应用的新型高效氨发动机技术 (HEAT-HD)
- 批准号:
10096638 - 财政年份:2024
- 资助金额:
$ 45.14万 - 项目类别:
Collaborative R&D
Three-dimensional solar-energy-driven hydrogen generation from ammonia
三维太阳能驱动的氨制氢
- 批准号:
DP240102787 - 财政年份:2024
- 资助金额:
$ 45.14万 - 项目类别:
Discovery Projects
Accurate Determination of Branching Fractions in Ammonia Combustion
氨燃烧中支化分数的准确测定
- 批准号:
2329341 - 财政年份:2024
- 资助金额:
$ 45.14万 - 项目类别:
Standard Grant
High-productivity ammonia electrosynthesis
高产氨电合成
- 批准号:
LP210301321 - 财政年份:2023
- 资助金额:
$ 45.14万 - 项目类别:
Linkage Projects